AU2003289603A1 - Tumor vaccine - Google Patents

Tumor vaccine

Info

Publication number: AU2003289603A1
Authority: AU; Australia
Prior art keywords: tumor vaccine; vaccine; tumor
Prior art date: 2002-11-29
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.): Abandoned

Application number

AU2003289603A

Inventor

Peng Cai

Ge Chen

Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)

PEL-FREEZ BIOTECHNOLOGY (BEIJING) Ltd

Original Assignee

PEL FREEZ BIOTECHNOLOGY BEIJIN

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2002-11-29

Filing date

2003-12-01

Publication date

2004-07-09

2003-12-01 Application filed by PEL FREEZ BIOTECHNOLOGY BEIJIN filed Critical PEL FREEZ BIOTECHNOLOGY BEIJIN

2004-07-09 Publication of AU2003289603A1 publication Critical patent/AU2003289603A1/en

Status Abandoned legal-status Critical Current

Classifications

- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/10—Cells modified by introduction of foreign genetic material
- C12N5/12—Fused cells, e.g. hybridomas
- C12N5/16—Animal cells
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K40/00—Cellular immunotherapy
- A61K40/10—Cellular immunotherapy characterised by the cell type used
- A61K40/19—Dendritic cells
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K40/00—Cellular immunotherapy
- A61K40/20—Cellular immunotherapy characterised by the effect or the function of the cells
- A61K40/24—Antigen-presenting cells [APC]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K40/00—Cellular immunotherapy
- A61K40/40—Cellular immunotherapy characterised by antigens that are targeted or presented by cells of the immune system
- A61K40/41—Vertebrate antigens
- A61K40/42—Cancer antigens
- A61K40/428—Undefined tumor antigens, e.g. tumor lysate or antigens targeted by cells isolated from tumor
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/80—Vaccine for a specifically defined cancer

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Animal Behavior & Ethology (AREA)
Epidemiology (AREA)
Chemical & Material Sciences (AREA)
Engineering & Computer Science (AREA)
Genetics & Genomics (AREA)
Organic Chemistry (AREA)
Wood Science & Technology (AREA)
Biomedical Technology (AREA)
Zoology (AREA)
Bioinformatics & Cheminformatics (AREA)
Biotechnology (AREA)
Microbiology (AREA)
General Chemical & Material Sciences (AREA)
Cell Biology (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Chemical Kinetics & Catalysis (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Biochemistry (AREA)
General Engineering & Computer Science (AREA)
Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

AU2003289603A 2002-11-29 2003-12-01 Tumor vaccine Abandoned AU2003289603A1 (en)

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date	Title
CN02153446A CN1446583A (en)	2002-11-29	2002-11-29	Composition, preparation and application scheme of tumor immunological therapy and preventative vaccine
CN02153446.2		2002-11-29
PCT/CN2003/001018 WO2004055053A1 (en)	2002-11-29	2003-12-01	Tumor vaccine

Publications (1)

Publication Number	Publication Date
AU2003289603A1 true AU2003289603A1 (en)	2004-07-09

Family

ID=28048698

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
AU2003289603A Abandoned AU2003289603A1 (en)	2002-11-29	2003-12-01	Tumor vaccine

Country Status (3)

Country	Link
CN (1)	CN1446583A (en)
AU (1)	AU2003289603A1 (en)
WO (1)	WO2004055053A1 (en)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
CN100392074C (en) *	2003-10-15	2008-06-04	上海海欣生物技术有限公司	Dendritic cell tumor vaccine and its preparation and use
CN100354002C (en) *	2005-05-31	2007-12-12	中国人民解放军第三军医大学第一附属医院	New type of cell vaccine with heteroimmune cell as cell vector and its prepn process
CN101724011B (en) *	2008-10-21	2011-11-23	南京瑞尔医药有限公司	Preparation method and application of tumor tissue complete antigen
US8309485B2 (en)	2009-03-09	2012-11-13	Chevron Phillips Chemical Company Lp	Methods for producing metal-containing sulfated activator-supports
EP2555627A4 (en) *	2010-04-06	2013-10-23	John W Holaday	METHODS OF TREATING CANCER
DE102012213838A1 (en) *	2012-08-03	2014-02-06	Katharina Pachmann	A method of culturing a subpopulation of circulating epithelial tumor cells from a body fluid
CN104651311B (en) *	2014-09-03	2018-03-13	深圳市茵冠生物科技有限公司	Prepare DC CTL kit and its application
CN105132386B (en) *	2015-09-02	2018-06-26	北京多赢时代科技有限公司	A kind of outer body secretion and preparation method thereof and its application as tumor vaccine
CN105063013B (en) *	2015-09-02	2018-05-15	北京多赢时代科技有限公司	A kind of fused cell and preparation method thereof and its application as tumor vaccine
CN112243382A (en) *	2018-01-18	2021-01-19	南佛罗里达大学	Dead antigen-stimulated immature heterologous dendritic cells as disease therapeutics
JP7282874B2 (en) *	2018-08-20	2023-05-29	中国科学院過程工程研究所	Exosome-based anti-tumor vaccine
JP2022542745A (en) *	2019-05-27	2022-10-07	錦高キャピタル株式会社	Dendritic cell-based cancer vaccine and preparation method thereof
CN113368226B (en) *	2021-06-30	2021-11-30	上海力沃生物科技有限公司	Pharmaceutical composition containing DC tumor vaccine and application thereof in treating cancer

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
GB9905124D0 (en) *	1999-03-05	1999-04-28	Smithkline Beecham Biolog	Novel compounds
US20030165483A1 (en) *	2000-07-10	2003-09-04	Ulrich Zimmermann	Method for the modification of biological cells
WO2002072013A2 (en) *	2001-03-09	2002-09-19	Baylor Research Institute	Method of treating malignancies through induction of blood immune responses
CN1168740C (en) *	2001-04-04	2004-09-29	上海美恩生物技术有限公司	Antigen-presenting cell/tumor cell conjugate modified by cytokine gene, its preparation method and use

2002
- 2002-11-29 CN CN02153446A patent/CN1446583A/en active Pending
2003
- 2003-12-01 AU AU2003289603A patent/AU2003289603A1/en not_active Abandoned
- 2003-12-01 WO PCT/CN2003/001018 patent/WO2004055053A1/en not_active Ceased

Also Published As

Publication number	Publication date
CN1446583A (en)	2003-10-08
WO2004055053A1 (en)	2004-07-01

Publication	Publication Date	Title
AUPS054702A0 (en)	2002-03-07	Cancer therapy
GB0213622D0 (en)	2002-07-24	Vaccine Corporation
GB0226722D0 (en)	2002-12-24	Vaccine
GB0225788D0 (en)	2002-12-11	Vaccine
AU2003247005A1 (en)	2004-02-02	Therapy combination
AU2003289603A1 (en)	2004-07-09	Tumor vaccine
AU2003285320A1 (en)	2004-06-07	Vaccine
AU2003245794A1 (en)	2003-09-04	Glycosaminoglycan-dnase combination therapy
GB0228715D0 (en)	2003-01-15	Vaccine
GB0209878D0 (en)	2002-06-05	Vaccine
PL376534A1 (en)	2006-01-09	Vaccine
AU2003273035A1 (en)	2004-05-04	Gene vaccine
AU2003237701A1 (en)	2003-12-12	Vaccines
AU2003900767A0 (en)	2003-03-13	Idiotypic vaccine
AUPS084502A0 (en)	2002-03-28	Anti-protozoal vaccine
GB0206595D0 (en)	2002-05-01	Vaccine
AU2003231937A1 (en)	2003-12-19	Therapeutic methods
IL156434A0 (en)	2004-01-04	Vaccine
AU2002238396A1 (en)	2002-08-12	Tumor vaccine
AU2002331950A1 (en)	2004-04-08	Vaccine
AUPS086102A0 (en)	2002-03-28	Vaccine iii
GB0223355D0 (en)	2002-11-13	Vaccine
GB0226179D0 (en)	2002-12-18	Vaccine
AU2002953515A0 (en)	2003-01-16	Therapeutic compounds - II
GB0218036D0 (en)	2002-09-11	Vaccine

Legal Events

Date	Code	Title	Description
2005-08-18	MK6	Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase